A sad day for science at the FDA

N Engl J Med. 2005 Dec 15;353(24):2619-21; author reply 2619-21.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Age Factors
  • Breast Neoplasms / chemically induced*
  • Contraceptives, Postcoital / adverse effects*
  • Drug Approval*
  • Female
  • Health Services Accessibility / legislation & jurisprudence
  • Humans
  • Levonorgestrel / adverse effects*
  • Multiple Sclerosis / chemically induced*
  • Nonprescription Drugs / adverse effects*
  • Politics
  • United States
  • United States Food and Drug Administration*

Substances

  • Contraceptives, Postcoital
  • Nonprescription Drugs
  • Levonorgestrel